Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer

NCT03574220 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No accrual - closed by PRMC

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Pembrolizumab
RADIATION: Stereotactic body radiotherapy

Sponsor

Case Comprehensive Cancer Center